Monash IVF Group (ASX:MVF) now expects fiscal 2025 underlying group net profit after tax to be about AU$27.5 million, compared with its previous guidance of between AU$30 million and AU$31 million, according to a Tuesday Australian bourse filing.
The company said its revised guidance reflects its assessment of softer market and operating conditions that worsened in April across all of its geographic markets.
The company added that its new Australian vitro fertilization (IVF) patient resgistration, returning IVF patients for stimulated cycles, and other indicators are currently consistent with the months before it dsiclosed the Brisbane incident, where an embryo was mistakenly implanted into the wrong patient at its Brisbane clinic, resulting in the birth of a child.
The company will disclose its fiscal 2025 results on Aug. 22.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.